DIABETAMIDE 5 |
MALIX |
GLYNASE |
CALABREN |
GLIBENCLAMIDE |
HB 419 |
U-26452 |
U-26,45 |
GLYNASE PRESTAB |
MICRONASE |
DIABETA |
LIBANIL |
DAONIL |
DIABETAMIDE 2.5 |
GLYBURIDE |
LEDERGLIB |
HB-419 |
EUGLUCON |
SEMI-DAONIL |
GLYBURIDE (MICRONIZED) |
GLIKEN |
DIABETA® |
GLIBENCLAMIDUM |
1-(P-(2-(5-CHLORO-2-METHOXYBENZAMIDO)ETHYL)BENZENESULFONYL)-3-CYCLOHEXYLUREA |
5-CHLORO-N-(2-(4-((((CYCLOHEXYLAMINO)CARBONYL)AMINO)SULFONYL)PHENYL)ETHYL)-2-METHOXYBENZAMIDE |
1-((P-(2-(5-CHLORO-O-ANISAMIDO)ETHYL)PHENYL)SULFONYL)-3-CYCLOHEXYLUREA |
GLIBENCLAMIDA |
GLYNASE® |
chembl:CHEMBL472 |
chemidplus:10238-21-8 |
drugbank:01016 |
pubchem.compound:3488 |
rxcui:4815 |
Drug Class | hypoglycemic agents |
Year of Approval | 1984 |
Drug Categories | hypoglycemia-associated agents |
FDA Approval | 1984 |
Drug Class | small molecule |
Drug Indications | Hypoglycemic Agents |
FDA Approval | approved |
Drug Indications | antidiabetic |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | cytochrome p-450 cyp2c9 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (weak) |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | oat1/slc22a6 inhibitors |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | photosensitizing agents |
blocker (inhibitory) |
Novel drug target | Established target |
Trial Name | glyburide + metformin,Glucovance |
Mechanism of Interaction | Sulfonylurea receptor 1, Kir6.2 blocker |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction? | True |
Endogenous Drug? | False |
Specific Action of the Ligand | None |
n/a |
Trial Name | - |
Novel drug target | Established target |
inhibitor (inhibitory) |
Specific Action of the Ligand | None |
Endogenous Drug? | False |
Direct Interaction? | False |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
GLYBURIDE | DrugBank Drug Name |
10238-21-8 | CAS Number |
Apo Glyburide Tab 2.5mg | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | alimentary tract and metabolism |
GLIBENCLAMIDE | Primary Drug Name |
Year of Approval | 1984 |
Drug Class | hypoglycemic agents |
Drug Indications | Hypoglycemic Agents |
Drug Class | small molecule |
FDA Approval | 1984 |
Drug Indications | antidiabetic |
Drug Class | Small molecule |
FDA Approval | approved |
C29076 | NCI drug code |
CHEMBL472 | ChEMBL Drug ID |
D05LYX | TTD Drug ID |
GLIBENCLAMIDE | GuideToPharmacology Ligand Name |